THE NEWS that a vaccine for meningitis B (MenB) will be offered to babies for free under the NHS has been welcomed by a Thornbury charity.

A price has been agreed between the government and the vaccine manufacturer GlaxoSmithKline enabling it to be offered for free.

The disease leads to death in 10 per cent of all cases and to long-term after effects in a further 36 per cent so the announcement is being celebrated by Meningitis Research Foundation (MRF).

Chris Head, chief executive of MRF said: “MenB has been at the top of this charity's agenda for decades and we are delighted that vaccinating all babies against this devastating disease is now within sight, cementing the UK’s position as a world leader in meningitis prevention.”

“When this vaccine is finally introduced it will save lives and spare countless families the trauma of seeing a loved one die or become seriously disabled because of MenB.

“The bitter experience of those who have been personally affected has been vital in our campaigning for this vaccine, demonstrating the compelling case for prevention. We pay tribute to them and pledge to continue supporting them.

“We do however remain concerned that there is no recommendation for teenagers, the second highest ‘at risk’ group, to be routinely vaccinated. Vaccinating this age group has the potential to protect the wider population because they are key to transmission and spread.”

Linda Glennie, head of research and medical information at MRF said: “After years of research it’s wonderful to see a MenB vaccine available for all babies in the UK. We pay tribute to all the scientists and health professionals involved in the creation of the vaccine.

“Our members and supporters have played an important role, demonstrating the burden of MenB disease and funding years of research, including studies that allowed the vaccine to be tested.

“Their continued support will help us evaluate the vaccine once implemented.”